MRUS
Merus BV
NASDAQ: MRUS · HEALTHCARE · BIOTECHNOLOGY
$90.00
+0.00% today
Updated 2025-12-30
Market cap
$6.83B
P/E ratio
—
P/S ratio
120.59x
EPS (TTM)
$-5.28
Dividend yield
—
52W range
$33 – $97
Volume
1.3M
Merus BV (MRUS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-18.2%
Last 4 quarters
Revenue YoY growth
-1.9%
Most recent quarter
EPS YoY growth
+13.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.3%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+0.5%
2025-07-30
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-10-30 | $-1.26 | +8.7% | $94.81 | $94.86 | +0.1% |
| 2025-07-30 | $-2.23 | -95.6% | $65.92 | $66.24 | +0.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-1.38 | $-1.26 | +8.7% | $10.37M | -1.9% |
| 2025-06-30 | $-1.14 | $-2.23 | -95.6% | $7.49M | +9.5% |
| 2025-03-31 | $-1.06 | $-1.40 | -31.6% | $24.48M | +234.9% |
| 2024-12-31 | $-0.90 | $-0.49 | +45.7% | $8.82M | +9.0% |
| 2024-09-30 | $-0.88 | $-1.46 | -65.9% | $10.57M | +1.3% |
| 2024-06-30 | $-0.76 | $-0.81 | -6.6% | $6.84M | -28.7% |
| 2024-03-31 | $-0.81 | $-0.59 | +27.2% | $7.31M | -41.3% |
| 2023-12-31 | $-0.74 | $-1.04 | -40.5% | $8.10M | -18.7% |
| 2023-09-30 | $-0.73 | $-0.43 | +41.1% | $10.44M | — |
| 2023-06-30 | $-0.88 | $-0.66 | +25.0% | $9.60M | — |
| 2023-03-31 | $-1.02 | $-0.86 | +15.7% | $12.44M | — |
| 2022-12-31 | $-0.83 | $-1.81 | -118.1% | $9.96M | — |
Frequently asked questions
Has Merus BV beaten earnings estimates?
Merus BV has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -18.2% over the last 4 quarters.
How does MRUS stock react to earnings?
MRUS stock has moved an average of +0.3% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Merus BV's revenue growth rate?
Merus BV reported year-over-year revenue growth of -1.9% in its most recent quarter, with EPS growing +13.7% year-over-year.